These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12546068)

  • 1. Diminished expression of the type II receptor for TGFbeta (TGFbetaRII) in T lymphocytes from patients with Sezary syndrome is not due to mutations in the receptor's poly-A tract: limitations of the standard RT-PCR in cDNA sequence analysis of homopolymeric base stretches.
    Zhang Q; Capocasale RJ; Fox FE; Bedian V; Vonderheid EC; Rook A; Moore JS; Nowell PC; Haines DS; Wasik MA
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):421-9. PubMed ID: 12546068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
    Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
    Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
    Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
    Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
    Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
    Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
    Park B; Jang JS; Park K
    Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.
    Baker K; Raut P; Jass JR
    J Pathol; 2007 Nov; 213(3):257-65. PubMed ID: 17893910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII.
    Barrett JM; Rovedo MA; Tajuddin AM; Jilling T; Macoska JA; MacDonald J; Mangold KA; Kaul KL
    Prostate; 2006 May; 66(6):632-50. PubMed ID: 16388503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma.
    Lynch MA; Nakashima R; Song H; DeGroff VL; Wang D; Enomoto T; Weghorst CM
    Cancer Res; 1998 Oct; 58(19):4227-32. PubMed ID: 9766642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas.
    Ikeda H
    Brain Tumor Pathol; 2006 Apr; 23(1):7-12. PubMed ID: 18095113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in expression of genes, mRNA, and proteins of transforming growth factor-beta receptor type I and type II in human pituitary adenomas.
    Fujiwara K; Ikeda H; Yoshimoto T
    Clin Neuropathol; 1998; 17(1):19-26. PubMed ID: 9496536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in T cell receptor zeta chain mRNA of peripheral T cells from systemic lupus erythematosus patients.
    Tsuzaka K; Takeuchi T; Onoda N; Pang M; Abe T
    J Autoimmun; 1998 Oct; 11(5):381-5. PubMed ID: 9802920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sézary syndrome.
    Bigler RD; Boselli CM; Foley B; Vonderheid EC
    Am J Pathol; 1996 Nov; 149(5):1477-83. PubMed ID: 8909237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of transforming growth factor beta receptor II, insulin growth factor receptor II genes in microsatellite unstable prostate carcinomas.
    Bhattacharyya N; Tao J; Klein EA; Banerjee S
    Oncol Rep; 2004 Jan; 11(1):231-6. PubMed ID: 14654931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers.
    Takenoshita S; Tani M; Nagashima M; Hagiwara K; Bennett WP; Yokota J; Harris CC
    Oncogene; 1997 Mar; 14(10):1255-8. PubMed ID: 9121777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No mutations of the Bub1 gene in human gastric and oral cancer cell lines.
    Nakagawa H; Yokozaki H; Oue N; Sugiyama M; Ishikawa T; Tahara E; Yasui W
    Oncol Rep; 2002; 9(6):1229-32. PubMed ID: 12375025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptor gene mutations in leukemic cells acquired in vitro and in vivo.
    Hillmann AG; Ramdas J; Multanen K; Norman MR; Harmon JM
    Cancer Res; 2000 Apr; 60(7):2056-62. PubMed ID: 10766198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma.
    Francis-Thickpenny KM; Richardson DM; van Ee CC; Love DR; Winship IM; Baguley BC; Chenevix-Trench G; Shelling AN
    Br J Cancer; 2001 Sep; 85(5):687-91. PubMed ID: 11531253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.